schizandrin b has been researched along with erythrosine in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (erythrosine) | Trials (erythrosine) | Recent Studies (post-2010) (erythrosine) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 15,483 | 108 | 2,574 |
| Protein | Taxonomy | schizandrin b (IC50) | erythrosine (IC50) |
|---|---|---|---|
| Genome polyprotein | Zika virus | 1.7 | |
| large T antigen | Betapolyomavirus macacae | 13.04 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Lu, Q; Pan, Q; Sun, M; Xu, X | 1 |
1 other study(ies) available for schizandrin b and erythrosine
| Article | Year |
|---|---|
Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclooctanes; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Lignans; Molecular Structure; Multidrug Resistance-Associated Proteins; Polycyclic Compounds; Probenecid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |